Scios And Medtronic To Develop Heart Failure Treatment

. has announced its entry into a research collaboration with Medtronic, Inc. to study the effects of Scios’ investigational agent Natrecor (nesiritide) in combination with Medtronic’s heart failure devices and implantable infusion systems.

“We are excited to establish this collaboration as both Scios and Medtronic have a shared commitment to the diagnosis and management of heart failure in all of its manifestations,” said Scios Chief Scientific Officer George F. Schreiner, M.D., Ph.D. “This research effort between the two companies explores the potential for new heart failure treatments combining Natrecor’s unique therapeutic properties with Medtronic’s approach to the treatment of heart failure.”

In the first of a planned program of pilot clinical studies, the hemodynamic and clinical effects of Natrecor, including the effects on spontaneous activity and controlled exercise tolerance, will be evaluated using information collected by Medtronic’s Chronicle Implantable Hemodynamic Monitor (IHM) both during and after infusions of Natrecor.

The pilot feasibility study is expected to begin this quarter at the Karolinska Hospital in Stockholm.

Both Natrecor and the Chronicle IHM are currently under clinical investigation in the United States.

Natrecor is currently being reviewed by the U.S. FDA as a potential treatment for acute CHF. If approved for marketing by the FDA, Natrecor would be the first new treatment available for acute CHF in over a decade.

The Chronicle system is being studied in a worldwide multicenter clinical trial.

Medtronic expects to file for U.S. and European marketing approvals for this system by the end of this year.

Scios is a biopharmaceutical company developing novel treatments for cardiovascular and inflammatory diseases.

The company’s disease-based technology platform integrates expertise in protein biology with combinatorial and medicinal chemistry to identify novel targets and rationally design large and small-molecule compounds to treat cardiovascular and inflammatory diseases, two of the world’s leading unmet medical needs.

Purchase Dragon Pharmaceutical On-line

Enantat 250 - Cheap Price

Administration: Injection
Basic Ingredient: Testosterone Enanthate
Branded by: Dragon Pharma LLC
Amount: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Primobolan 100 - Discount Price

Administration: Injection
Principal Substance: Methenolone Enanthate
Produced by: Dragon Pharmaceuticals
Amount: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $55.00

Cypionat 250 - Discount Price

Administration: Injection
Main Component: Testosterone Cypionate
Made by: Dragon Pharma Labs
Pack: 30 x 10 mL vial (250 mg/mL)
Price: 30 x $25.00

Turanabol - Cheap Price

Administration: Oral
Principal Ingredient: Chlorodehydromethyltestosterone
Produced by: Dragon Pharma LLC
Amount: 20 x 100 pills (10 mg/pill)
Price: 20 x $60.00

Clenbuterol - Bulk Price

Administration: Oral
Active Chemical Name: Clenbuterol Hydrochloride
Branded by: Dragon Pharmaceutical
Package: 10 x 100 pastilles (40 mcg/tab)
Price: 10 x $25.00

Cut Mix 150 - Discount Price

Administration: Injection
Base Component: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharmaceuticals
Package: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $36.00

Dianabol 20 - Discount Price

Administration: Oral
Main Constituent: Methandrostenolone
Produced by: Dragon Pharma LLC
Pack: 30 x 100 pills (20 mg/tab)
Price: 30 x $26.00

NPP 150

Injectable Anabolic Steroid
Base Chemical Name: Nandrolone Phenylpropionate
Produced by: Dragon Pharmaceuticals
Package: 1 X 10 ml (150 mg/ml)

Masteron 200 - Cheap Price

Administration: Injection
Main Substance: Drostanolone Enanthate
Made by: Dragon Pharma
Pack: 20 x 10 mL vial (200 mg/mL)
Price: 20 x $60.00

Cypionat 250 - Cheap Price

Administration: Injection
Basal Substance: Testosterone Cypionate
Made by: Dragon Pharmaceuticals
Amount: 20 x 10 mL vial (250 mg/mL)
Price: 20 x $30.00

Cypionat 250 - Bulk Price

Administration: Injection
Basic Substance: Testosterone Cypionate
Producer: Dragon Pharmaceuticals
Unit: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00


Base Ingredient: Tamoxifen Citrate
Made by: Dragon Pharmaceuticals
Unit: 100 tabs (50 mg/pill)